14 December 1998 00:00 [Source: ICB Americas]After completing a series of investments last October, estimated at nearly $23 million, Laporte Fine Chemicals is considering further improvements at its plant in Teesside, the UK.
Laporte has increased the site's capacity by 50 cubic meters. The completed project includes expanded production capabilities, enhanced cGMP storage areas and a new distillation plant, as well as more advanced incineration capabilities and the installation of new and upgraded reactors.
Manufacturing is already in progress at the facility, which produces late-stage pharmaceutical intermediates for a US and a British manufacturer. "We are close to being filled," notes Arthur Jackson, business director for Laporte Fine Chemicals. He adds that the company considers further expansions by the end of next year.
Outsourcing by pharmaceutical players is still strong, Mr. Jackson notes. But he adds that to attract smaller custom manufactures, it is important to offer top quality products.
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.